Deutsche Biotech Innovativ AG Logo

Deutsche Biotech Innovativ AG

Develops therapeutics for serious diseases using innovative blood biomarkers.

DBI | F

Overview

Corporate Details

ISIN(s):
DE000A0Z25L1
LEI:
391200BIDNL2ZOKI1M61
Country:
Germany
Address:
Neuendorfstraße 15a, 16761 Hennigsdorf

Description

Deutsche Biotech Innovativ AG is a biotechnology company focused on the research and clinical development of therapeutic solutions for serious diseases. The company utilizes innovative blood biomarkers to guide its development process. Its lead product candidate is Adrecizumab, a monoclonal, adrenomedullin-specific antibody designed to treat conditions involving endothelial barrier dysfunction. Adrecizumab has completed Phase I/II clinical trials for the treatment of septic shock.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2015-01-22 15:13
Deutsche Biotech Innovativ AG: Erfolgreiche Kapitalerhohung und Portfolioerweit…
German 4.4 KB
2014-12-15 08:00
Deutsche Biotech Innovativ AG: Kapitalerhohung beschlossen und bereits erfolgre…
German 3.3 KB
2014-10-21 08:00
Venetus Beteiligungen AG: Umfirmierung in 'Deutsche Biotech Innovativ AG' ist e…
German 3.1 KB
2014-08-25 08:00
Venetus Beteiligungen AG: Ordentliche Hauptversammlung 2014 stimmt allen Tageso…
German 5.0 KB
2014-05-06 12:34
Venetus Beteiligungen AG: -Jahresabschluss 2013 festgestellt -Grundung einer…
German 4.5 KB
2013-05-30 07:55
Venetus Beteiligungen AG: Ordentliche Hauptversammlung 2013 stimmt allen Tageso…
German 4.7 KB
2013-04-30 11:19
Venetus Beteiligungen AG: Barkapitalerhohung erfolgreich abgeschlossen - Haupt…
German 2.4 KB
2013-03-08 20:33
Venetus Beteiligungen AG: - Jahresabschluss 2012 festgestellt, Barkapitalerhohu…
German 5.1 KB
2012-11-26 11:11
Venetus Beteiligungen AG: Notierungsaufnahme im Primarmarkt der Borse Dusseldorf
German 3.6 KB
2012-11-15 10:39
Venetus Beteiligungen AG: AdrenoMed AG veroffentlicht Pressemitteilung zur Seps…
German 5.4 KB
2012-10-25 08:28
Venetus Beteiligungen AG: Fordermittel bewilligt
German 4.9 KB
2012-09-03 07:45
Venetus Beteiligungen AG: Hauptversammlung stimmt Tagesordnungspunkten vorbehal…
German 4.5 KB
2012-04-05 18:51
Venetus Beteiligungen AG: Aufnahme der Kursnotierung im Freiverkehr der Borse D…
German 2.2 KB
2012-04-03 12:00
Venetus Beteiligungen AG: Jahresabschluss 2011 festgestellt
German 4.6 KB
2012-03-20 16:43
Venetus Beteiligungen AG: Uberzeugende erste Tierergebnisse der AdrenoMed AG be…
German 3.3 KB

Automate Your Workflow. Get a real-time feed of all Deutsche Biotech Innovativ AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Deutsche Biotech Innovativ AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Deutsche Biotech Innovativ AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.